Company information
- Ticker
- 6830
- Country
- Taiwan
- Sector
- Information Technology
- Industry
- Tech Hardware
MSS Business Summary
MSS (Macro-Surge Scientific Co., Ltd.) operates as a specialized distributor of high-end medical devices, primarily generating revenue through the sale of interventional cardiology, neurovascular, and peripheral vascular products to healthcare institutions across Taiwan. Its business model integrates product procurement with high-value clinical support services, where revenue is driven by the volume of surgical consumables and capital equipment sales, alongside technical consulting fees for complex procedures. The company’s primary business segments are categorized by clinical application: Cardiovascular Intervention, Neurovascular Intervention, and Peripheral Vascular/Structural Heart solutions. Within the Taiwanese market, MSS competes directly with Excelsior Medical Co., Ltd. (4126.TW), Health-Care Instruments Co., Ltd. (4116.TW), and Bioteque Corporation (4107.TW). MSS distinguishes itself through its exclusive distribution agreements with top-tier global manufacturers and a specialized technical team that provides intra-operative support, positioning the firm as a premium, service-oriented intermediary rather than a high-volume commodity wholesaler. The company is led by Chairman and General Manager Chen Chien-Chung (陳建中), who established MSS with a strategic focus on the high-growth vascular intervention sector. The leadership team is composed of industry veterans with significant pedigrees in medical device regulatory affairs and clinical marketing, often drawing talent from multinational corporations to manage its complex supply chain and hospital relationships. The board of directors includes strategic oversight from seasoned professionals in the Taiwanese medical technology ecosystem, ensuring alignment with National Health Insurance (NHI) pricing trends and regulatory shifts. Notable institutional backing has historically come from domestic investment funds focused on the biotechnology and healthcare services sectors, reinforcing MSS’s reputation as a stable, growth-oriented entity within the TWSE medical equipment category.